meRfi®-GM
Lacticaseibacillus rhamnosus
Welcome to meRfi-GM!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Navigation
Contents
GeneBankAC: CP003094
Collection numbers: ATCC 8530 / ATCC 21052
Lacticaseibacillus (Lactobacillus) rhamnosus belongs to the species in the healthy human gut; the abundance is low: about 0.01% of all species in the healthy human gut
Antidiabetic properties
Lacticaseibacillus (Lactobacillus) rhamnosus is a probiotic bacterium that has been studied for its potential health benefits. It has been used in the reformulation of traditional Iranian food to investigate its effect on diabetic and non-diabetic rats
Additionally, research has been conducted on the viability and antidiabetic potential of Lacticaseibacillus (Lactobacillus) rhamnosus in yogurt ice cream after in vitro digestion, showing …
References (Sources)
- Baseline human gut microbiota profile in healthy people and standard reporting template
- Beneficial Shifts in Gut Microbiota by Lacticaseibacillus rhamnosus R0011 and Lactobacillus helveticus R0052 in Alcoholic Hepatitis
- Cutting Edge: Probiotics and Fecal Microbiota Transplantation in Immunomodulation
- Differential effect on cell-mediated immunity in human volunteers after intake of different lactobacilli
- Efficacy and safety of Lacticaseibacillus rhamnosus R0011 and Lactobacillus helveticus R0052 as an adjuvant for Helicobacter pylori eradication: a double-blind, randomized, placebo-controlled study
- Impact of electro-activated whey on growth, acid and bile resistance of Lacticaseibacillus rhamnosus GG and Lactobacillus acidophilus ATCC 4356
- Lactobacillus supplementation for diarrhoea related to chemotherapy of CRC: a randomised study